Ameritas Advisory Services’s 10x Genomics TXG Stock Holding History

Ameritas Advisory Services’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4K	Buy	+297	New	+$7.78K	﹤0.01%	1451
2024 Q3	–	Sell	-20,000	Closed	-$389K	–	937
2024 Q2	$389K	Sell	20,000 -5,417	-21%	-$142K	0.01%	654
2024 Q1	$954K	Buy	+25,417	New	+$1.12M	0.04%	390
2023 Q4	–	Sell	-25,422	Closed	-$1.05M	–	841
2023 Q3	$1.05M	Buy	+25,422	New	+$1.32M	0.05%	330
2023 Q2	–	Sell	-25,426	Closed	-$1.38M	–	2372
2023 Q1	$1.38M	Sell	25,426 -3	-0%	-$140	0.07%	259
2022 Q4	$927K	Sell	25,429 -2	-0%	-$65	0.04%	371
2022 Q3	$724K	Buy	25,431 +11	+0%	+$419	0.04%	355
2022 Q2	$1.15M	Hold	25,420	–	–	0.07%	266
2022 Q1	$1.93M	Hold	25,420	–	–	0.07%	216
2021 Q4	$3.79M	Buy	+25,420	New	+$3.89M	0.14%	124

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameritas Advisory Services's TXG Position: Q2 2026 in Review

Ameritas Advisory Services opened a new position in 10x Genomics (TXG) in Q2 2026: 297 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #1451 among its holdings. This is a return to the name: Ameritas Advisory Services previously reported a position in TXG as recently as Q2 2024.

Ameritas Advisory Services first reported a position in TXG in Q4 2021 and has held it in 10 quarters since. The position peaked at $3.79M in Q4 2021. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

Ameritas Advisory Services held 297 shares of 10x Genomics worth $11.4K as of Q2 2026.
10x Genomics was a new Ameritas Advisory Services position in Q2 2026.
10x Genomics made up ﹤0.01% of Ameritas Advisory Services's portfolio in Q2 2026, its #1451 holding.
Ameritas Advisory Services first reported a position in 10x Genomics in Q4 2021 and has held it in 10 quarters since.
Ameritas Advisory Services's 10x Genomics position peaked at $3.79M in Q4 2021.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.